PRECISEDX

precisedx-logo

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes. Clinical teams can rely on PreciseDx for unmatched insights and actionable intelligence in determining the best treatment for each patient. Combining the power of artificial intelligence with its proprietary Morphology Feature Arrayโ„ข, PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making.

#SimilarOrganizations #People #Financial #Event #Website #More

PRECISEDX

Social Links:

Industry:
Health Care

Founded:
2019-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.precisedx.ai

Total Employee:
1+

Status:
Active

Contact:
646-818-9330

Email Addresses:
[email protected]

Total Funding:
31.45 M USD

Technology used in webpage:
Euro Apple Mobile Web Clips Icon Amazon LetsEncrypt AJAX Libraries API CloudFront Amazon S3 CDN Gravity Forms GoDaddy Fastly


Similar Organizations

foundation-medicine-logo

Foundation Medicine

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

Current Employees Featured

michael-j-donovan_image

Michael J. Donovan
Michael J. Donovan Co-Founder and Chief Medical Officer @ PreciseDx
Co-Founder and Chief Medical Officer
2021-02-01

carlos-cordon_image

Carlos Cordon
Carlos Cordon Co-Founder and Chairman of the Advisory Board @ PreciseDx
Co-Founder and Chairman of the Advisory Board
2021-02-01

jack-zeineh_image

Jack Zeineh
Jack Zeineh Co-Founder and Chief Technology Officer @ PreciseDx
Co-Founder and Chief Technology Officer
2021-02-01

gerardo-fernandez_image

Gerardo Fernandez
Gerardo Fernandez Chief Scientific Officer and Founder @ PreciseDx
Chief Scientific Officer and Founder
2021-02-01

bradley-gendell_image

Bradley Gendell
Bradley Gendell Chief Financial Officer @ PreciseDx
Chief Financial Officer
2023-01-01

wayne-brinster_image

Wayne Brinster
Wayne Brinster President & CEO @ PreciseDx
President & CEO
2021-09-01

Founder


carlos-cordon_image

Carlos Cordon

gerardo-fernandez_image

Gerardo Fernandez

jack-zeineh_image

Jack Zeineh

michael-j-donovan_image

Michael J. Donovan

Investors List

laboratory-corporation-of-america_image

LabCorp

LabCorp investment in Series B - PreciseDx

genhenn-venture_image

GenHenn Venture

GenHenn Venture investment in Series B - PreciseDx

eventide-asset-management_image

Eventide

Eventide investment in Series B - PreciseDx

quest-diagnostics_image

Quest Diagnostics

Quest Diagnostics investment in Series B - PreciseDx

ibm-ventures_image

IBM Ventures

IBM Ventures investment in Series A - PreciseDx

merck-global-health-innovation-fund_image

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund investment in Series A - PreciseDx

mount-sinai-health-system_image

Mount Sinai Health System

Mount Sinai Health System investment in Series A - PreciseDx

agilent_image

Agilent Technologies

Agilent Technologies investment in Series A - PreciseDx

Key Employee Changes

Date New article
2023-02-21 PreciseDx Appoints Bradley Gendell as Chief Financial Officer

Official Site Inspections

http://www.precisedx.ai Semrush global rank: 9.69 M Semrush visits lastest month: 369

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "PreciseDx"

PreciseDx - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 646-818-9330 PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk โ€ฆSee details»

PreciseDx

PreciseBreastโ„ข uses AI-image analysis of a digitized H&E-stained slide from the patientโ€™s stored tissue. ... Why PreciseDx PreciseBreast Resources About Us. Who We Serve. For Oncologists For Breast Surgeons For Pathologists For โ€ฆSee details»

PreciseDx - LinkedIn

PreciseDx | 1,778 followers on LinkedIn. Innovating breast cancer diagnostic testing with PreciseBreast | PreciseDx® is innovating oncology diagnostics, leveraging Artificial Intelligence (AI ...See details»

PreciseDx 2025 Company Profile: Valuation, Funding & Investors

Developer of artificial intelligence-guided pathology diagnostics designed to improve patient outcomes in the field of cancer and other diseases. The company's commercial, regulatory โ€ฆSee details»

PreciseDx | artificial intelligence, cancer risk assessments, Zoonop

With AI-driven solutions, PreciseDx has successfully raised over $31.5 million, including a notable Series B round led by Eventide Asset Management and several healthcare industry leaders. โ€ฆSee details»

Precisedx, Inc. Company Profile | New York, NY | Competitors ...

Find company research, competitor information, contact details & financial data for Precisedx, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»

PreciseDx - Products, Competitors, Financials, Employees, โ€ฆ

About PreciseDx® Founded in 2020, PreciseDx is leveraging AI-powered digital pathology in oncology diagnostics to predict the risk and recurrence of cancer. Combining AI-image โ€ฆSee details»

PreciseDx Company Profile - Office Locations, Competitors ... - Craft

PreciseDx is a cancer risk stratification company that provides patient-specific risk information through the analysis of morphology features. Its AI-powered predictive platform creates โ€ฆSee details»

PreciseDx AI diagnostic can detect early-stage Parkinson's

Apr 10, 2025 PreciseDx's diagnostic relies instead on peripheral nerve tissue taken from the salivary glands of the living patient, using AI to look for LTS and other morphological features โ€ฆSee details»

Why PreciseDx

Our mission at PreciseDx® is to deliver objective, accurate and reliable reporting of key clinical information within hours, to improve comprehensive decision-making for patients affected by โ€ฆSee details»

PreciseDx Raises $10.75 Million Series A Preferred from โ€ฆ

Jan 11, 2022 Leveraging AI insights and data derived from high-volume, well-annotated study populations, PreciseDx offers breast cancer diagnostic test services, with a prostate cancer test in development.See details»

PreciseDx Secures $20.7 Million Series B to Advance AI โ€ฆ

NEW YORK, Aug. 21, 2024 /PRNewswire/ -- PreciseDx®, a leading innovator in oncology diagnostics leveraging Artificial Intelligence (AI) for new, morphology-driven disease analysis, today ...See details»

PreciseDx Company Profile | Management and Employees List

Www.precisedx.ai PreciseDx Profile and History PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology โ€ฆSee details»

PreciseDx Secures $20.7M to Improve Diagnostics in Oncology โ€ฆ

Sep 3, 2024 PreciseDx, a pioneering medical technology leveraging the power of artificial intelligence (AI) to improve diagnostics in oncology, has secured $20.7 million in a series B โ€ฆSee details»

Study Results from COTA, PreciseDx, and Baptist Health South โ€ฆ

NEW YORK, Dec. 9, 2024 /PRNewswire/ โ€” COTA Inc., a leader in real-world data (RWD) and analytics for oncology, PreciseDx, an innovator in AI-powered digital pathology focused on โ€ฆSee details»

PreciseDx - Contacts, Employees, Board Members, Advisors

Organization. PreciseDx . Connect to CRM . Save . Summary. Financials. People. Technology. ... Number of Board Member and Advisor Profiles 1. Contacts 10. About. PreciseDx has 6 current โ€ฆSee details»

PreciseDx - Overview, News & Similar companies | ZoomInfo.com

View PreciseDx (www.precisedx.ai) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more. โ€ฆSee details»

PreciseDx - Funding, Financials, Valuation & Investors - Crunchbase

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology. ... Experience the new Crunchbase, powered โ€ฆSee details»

Invest In PreciseDx Stock | Buy Pre-IPO Shares | EquityZen

Dec 6, 2024 Combining the power of artificial intelligence with its proprietary Morphology Feature Arrayโ„ข, PreciseDx creates disease-specific assays that deliver new levels of pathology โ€ฆSee details»

AI-Driven Organizational Structure for Successful AI Transformation

Mar 28, 2025 Implementing an AI transformation demands rethinking traditional organizational structures. Successful AI teams require autonomy, flexibility, iterative practices, and extensive โ€ฆSee details»

linkstock.net © 2022. All rights reserved